Revenue Summary of Azitra, Inc.

Azitra, Inc.'s latest annual revenue in 2023 was 686 Thousand USD , up 141.55% from previous year.
Azitra, Inc.'s latest quarterly revenue in 2024 Q2 was 7500.00 USD , down 0.0% from previous quarter.
Azitra, Inc. reported a annual revenue of 284 Thousand USD in annual revenue 2022, up 158.18% from previous year.
Azitra, Inc. reported a annual revenue of 110 Thousand USD in annual revenue 2021, down 0.0% from previous year.
Azitra, Inc. reported a quarterly revenue of - USD for 2024 Q1, down -100.0% from previous quarter.
Azitra, Inc. reported a quarterly revenue of 310.7 Thousand USD for 2023 Q3, up 80.64% from previous quarter.

Annual Revenue Chart of Azitra, Inc. (2023 - 2021)

Name	Revenue	Revenue Difference
AIM ImmunoTech Inc.	202 Thousand USD	-239.604%
Ampio Pharmaceuticals, Inc.	- USD	-Infinity%
Armata Pharmaceuticals, Inc.	4.52 Million USD	84.853%
Actinium Pharmaceuticals, Inc.	81 Thousand USD	-746.914%
Can-Fite BioPharma Ltd.	743 Thousand USD	7.672%
Chromocell Therapeutics Corporation	- USD	-Infinity%
Calidi Biotherapeutics, Inc.	- USD	-Infinity%
CEL-SCI Corporation	- USD	-Infinity%
iBio, Inc.	225 Thousand USD	-204.889%
Lineage Cell Therapeutics, Inc.	8.94 Million USD	92.331%
MAIA Biotechnology, Inc.	- USD	-Infinity%
Matinas BioPharma Holdings, Inc.	1.09 Million USD	37.409%
Navidea Biopharmaceuticals, Inc.	65.65 Thousand USD	-944.903%
NovaBay Pharmaceuticals, Inc.	14.72 Million USD	95.342%
NanoViricides, Inc.	- USD	-Infinity%
Oragenics, Inc.	37.65 Thousand USD	-1721.9%
BiomX Inc.	-357 Thousand USD	292.157%
BiomX Inc.	-357 Thousand USD	292.157%
Protalix BioTherapeutics, Inc.	65.49 Million USD	98.953%
Palatin Technologies, Inc.	4.49 Million USD	84.722%
Scorpius Holdings, Inc.	6.99 Million USD	90.193%